Jie Qing

744 total citations
28 papers, 604 citations indexed

About

Jie Qing is a scholar working on Hepatology, Molecular Biology and Epidemiology. According to data from OpenAlex, Jie Qing has authored 28 papers receiving a total of 604 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hepatology, 11 papers in Molecular Biology and 8 papers in Epidemiology. Recurrent topics in Jie Qing's work include Hepatitis C virus research (9 papers), Viral Infections and Immunology Research (6 papers) and Hippo pathway signaling and YAP/TAZ (5 papers). Jie Qing is often cited by papers focused on Hepatitis C virus research (9 papers), Viral Infections and Immunology Research (6 papers) and Hippo pathway signaling and YAP/TAZ (5 papers). Jie Qing collaborates with scholars based in China, United States and Canada. Jie Qing's co-authors include Yaxin Wang, Yuna Sun, Zihe Rao, Linqi Zhang, Lei Liu, Zheng Yin, Zhiyong Lou, Lin Cao, Jian Li and Wenzhong Yan and has published in prestigious journals such as Environmental Science & Technology, PLoS ONE and Chemical Communications.

In The Last Decade

Jie Qing

28 papers receiving 595 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jie Qing China 16 256 139 125 113 109 28 604
Joo‐Youn Lee South Korea 15 282 1.1× 27 0.2× 102 0.8× 117 1.0× 102 0.9× 66 638
Qingshan Zhang China 16 330 1.3× 45 0.3× 100 0.8× 88 0.8× 138 1.3× 70 807
Alexander Herrmann Germany 12 431 1.7× 29 0.2× 138 1.1× 242 2.1× 44 0.4× 25 829
Thomas Hesson United States 12 395 1.5× 160 1.2× 74 0.6× 132 1.2× 40 0.4× 16 687
Dorothy M. DeLisle United States 4 229 0.9× 169 1.2× 132 1.1× 70 0.6× 99 0.9× 5 499
Giuseppe Belardo Italy 12 277 1.1× 38 0.3× 98 0.8× 181 1.6× 33 0.3× 13 656
Megan H. Powdrill Canada 10 165 0.6× 34 0.2× 138 1.1× 157 1.4× 42 0.4× 18 407
S. Benzaria France 11 335 1.3× 26 0.2× 370 3.0× 183 1.6× 139 1.3× 25 638
M. E. Marongiu Italy 13 156 0.6× 38 0.3× 152 1.2× 70 0.6× 133 1.2× 36 453

Countries citing papers authored by Jie Qing

Since Specialization
Citations

This map shows the geographic impact of Jie Qing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Qing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Qing more than expected).

Fields of papers citing papers by Jie Qing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jie Qing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Qing. The network helps show where Jie Qing may publish in the future.

Co-authorship network of co-authors of Jie Qing

This figure shows the co-authorship network connecting the top 25 collaborators of Jie Qing. A scholar is included among the top collaborators of Jie Qing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jie Qing. Jie Qing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Ying, et al.. (2025). Targeting p97/Valosin-Containing Protein Promotes Hepatic Stellate Cell Senescence and Mitigates Liver Fibrosis. DNA and Cell Biology. 44(3). 132–143. 2 indexed citations
2.
Xia, Tong, Ming‐Qing Li, Sung Yang, et al.. (2025). A dual-functional mitochondrial probe for melanoma visualization and PI3K/AKT/mTOR-EMT signaling axis-mediated antitumor therapy. Colloids and Surfaces B Biointerfaces. 254. 114847–114847. 2 indexed citations
3.
Mi, Jinxing, Hao Liu, Shan Yang, et al.. (2025). Dual Activation of Molecular NO and O2 on a Pr-Doped CeO2-TiO2 Catalyst for the Simultaneous Catalytic Purification of NOx and Toluene. Environmental Science & Technology. 59(22). 11321–11329. 2 indexed citations
4.
Wang, Lu, Lu Wang, Yuwei Zhang, et al.. (2022). Pharmacological targeting of cGAS/STING-YAP axis suppresses pathological angiogenesis and ameliorates organ fibrosis. European Journal of Pharmacology. 932. 175241–175241. 18 indexed citations
5.
Zhang, Yuwei, Xue Yang, Xia Wu, et al.. (2022). Targeted inhibition of the immunoproteasome blocks endothelial MHC class II antigen presentation to CD4+ T cells in chronic liver injury. International Immunopharmacology. 107. 108639–108639. 11 indexed citations
6.
Qing, Jie, Yafeng Ren, Yuwei Zhang, et al.. (2021). Dopamine receptor D2 antagonism normalizes profibrotic macrophage-endothelial crosstalk in non-alcoholic steatohepatitis. Journal of Hepatology. 76(2). 394–406. 71 indexed citations
7.
Ren, Yafeng, Yuwei Zhang, Lu Wang, et al.. (2021). Selective Targeting of Vascular Endothelial YAP Activity Blocks EndMT and Ameliorates Unilateral Ureteral Obstruction-Induced Kidney Fibrosis. ACS Pharmacology & Translational Science. 4(3). 1066–1074. 20 indexed citations
8.
Qing, Jie, Xiaoheng Liu, Mengjie Zhou, et al.. (2020). Hippo/YAP Pathway Plays a Critical Role in Effect of GDNF Against Aβ-Induced Inflammation in Microglial Cells. DNA and Cell Biology. 39(6). 1064–1071. 28 indexed citations
9.
Qing, Jie, et al.. (2018). GP205, a new hepatitis C virus NS3/4A protease inhibitor, displays higher metabolic stability in vitro and drug exposure in vivo. Acta Pharmacologica Sinica. 39(11). 1746–1752. 3 indexed citations
10.
Cao, Lin, Jizheng Chen, Yaxin Wang, et al.. (2018). Identification of serotonin 2A receptor as a novel HCV entry factor by a chemical biology strategy. Protein & Cell. 10(3). 178–195. 14 indexed citations
11.
Han, Zhiqiang, Xiao Liang, Yaxin Wang, et al.. (2016). The discovery of indole derivatives as novel hepatitis C virus inhibitors. European Journal of Medicinal Chemistry. 116. 147–155. 16 indexed citations
12.
Wei, Yu, Jinlong Li, Jie Qing, et al.. (2016). Discovery of Novel Hepatitis C Virus NS5B Polymerase Inhibitors by Combining Random Forest, Multiple e-Pharmacophore Modeling and Docking. PLoS ONE. 11(2). e0148181–e0148181. 47 indexed citations
13.
Yan, Wenzhong, Jie Qing, Jin Huang, et al.. (2015). Identification, synthesis and pharmacological evaluation of novel anti-EV71 agents via cyclophilin A inhibition. Bioorganic & Medicinal Chemistry Letters. 25(24). 5682–5686. 12 indexed citations
14.
Qing, Jie, Neil Shaw, Li Lei, et al.. (2015). Studies on Inhibition of Proliferation of Enterovirus-71 by Compound YZ-LY-0. International Journal of Biological Sciences. 11(11). 1337–1347. 4 indexed citations
15.
Yan, Wenzhong, Jie Qing, Fei Mao, et al.. (2015). Discovery of Novel Small Molecule Anti-HCV Agents via the CypA Inhibitory Mechanism Using O-Acylation-Directed Lead Optimization. Molecules. 20(6). 10342–10359. 16 indexed citations
16.
Qing, Jie, Rui Luo, Yaxin Wang, et al.. (2015). Resistance analysis and characterization of NITD008 as an adenosine analog inhibitor against hepatitis C virus. Antiviral Research. 126. 43–54. 15 indexed citations
17.
Qing, Jie, et al.. (2014). Design and synthesis of imidazo[1,2-α][1,8]naphthyridine derivatives as anti-HCV agents via direct C–H arylation. Organic & Biomolecular Chemistry. 12(15). 2344–2348. 27 indexed citations
18.
Qing, Jie, Yaxin Wang, Yuna Sun, et al.. (2014). Cyclophilin A Associates with Enterovirus-71 Virus Capsid and Plays an Essential Role in Viral Infection as an Uncoating Regulator. PLoS Pathogens. 10(10). e1004422–e1004422. 76 indexed citations
19.
Wang, Yaxin, Jie Qing, Yuna Sun, & Zihe Rao. (2013). Suramin inhibits EV71 infection. Antiviral Research. 103. 1–6. 37 indexed citations
20.
Cui, Hong‐Kui, Jie Qing, Ye Guo, et al.. (2013). Stapled peptide-based membrane fusion inhibitors of hepatitis C virus. Bioorganic & Medicinal Chemistry. 21(12). 3547–3554. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026